Kinnier C V, Eu J P C, Davis R D, Howell D N, Sheets J, Palmer S M
Division of Pulmonary Medicine, Duke University Medical Center, Durham, NC, USA.
Am J Transplant. 2008 Sep;8(9):1946-50. doi: 10.1111/j.1600-6143.2008.02340.x. Epub 2008 Jul 28.
Lymphangiomatosis is a rare disease of lymphatic proliferation for which no adequate treatment is known. We report the first successful case of bilateral lung transplantation for the treatment of end-stage pulmonary lymphangiomatosis. A successful outcome was achieved with continued survival beyond 4 years posttransplant and stable lung function. The primary obstacles to significant gains in pulmonary function were thoracic, skeletal and abdominal lymphangiomatosis, which led to pulmonary restriction. Our report demonstrates that pulmonary lymphangiomatosis should be included among those diseases for which lung transplantation is considered potentially beneficial treatment but also emphasizes the importance of screening patients carefully for chest wall and abdominal lymphangiomas that may impede recovery.
淋巴管瘤病是一种罕见的淋巴管增生性疾病,目前尚无有效的治疗方法。我们报告了首例成功进行双侧肺移植治疗终末期肺淋巴管瘤病的病例。移植后患者存活超过4年,肺功能稳定,取得了成功的治疗效果。肺功能显著改善的主要障碍是胸、骨骼和腹部的淋巴管瘤病,这导致了肺功能受限。我们的报告表明,肺淋巴管瘤病应被列入那些被认为肺移植可能是有益治疗的疾病之中,但同时也强调了仔细筛查可能阻碍恢复的胸壁和腹部淋巴管瘤的重要性。